
ASSOCIATION BETWEEN LOSS OF Dp140 AND COGNITIVE
IMPAIRMENT IN DUCHENNE AND BECKER DYSTROPHIES Chamova T1,*, Guergueltcheva V1, Raycheva M1, Todorov T2,3,
Genova J2, Bichev S4, Bojinova V5, Mitev V3, Tournev I1,6, Todorova A2,3 *Corresponding Author: Teodora Chamova, M.D., Ph.D., Clinic of Neurology, University Hospital “Alexandrovska”,
1 Georgi Sofiiski str., Sofia 1431, Bulgaria; Tel.: +359-889802252; Fax: +359-2-9526787; E-mail: teodoratch@abv.bg page: 21
|
RESULTS
Genetic, clinical and neuropsychological data are
summarized in Table 1. Of the 53 patients included
in the study, 38 (72.0%) were diagnosed as DMD, 13
(24.0%) as BMD and two (4.0%) were considered to
have an intermediate phenotype. In total 30 (78.9%)
out of 38 DMD patients were found to have molecular
deletions in the DMD gene, seven carried point mutations
and one was found to have duplications in the
DMD gene. In the 38 DMD patients, the deletions
with defined boundaries and the point mutations, were
predicted to disrupt the dystrophin reading-frame.
For the 13 BMD patients and two IMD patients, the
identified deletions were inframe mutations. Deletions
were heterogeneous in size and evenly distributed
along the gene.
We compared the IQ of the patients with DMD,
IMD and BMD, in order to verify if there is a statistically
significant difference between the global
intelligence of these allelic diseases, differing by the severity of muscle weakness. The mean IQ of our
DMD and IMD patients was 86.98 ± 15.34, varying
between 53 and 124, whereas the mean IQ of BMD
patients was 85.62 ± 10.40, with a smaller variation
between 65 and 105. Fifteen percent of the DMD
and IMD patients (6/40) had mild mental retardation,
while 7.0% (1/13) of the BMD patients were
mildly mentally retarded (IQ bellow 70). Four DMD (10.0%) and two BMD (16.0%) patients showed a
borderline cognitive level (70
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|